Form 4: Itron Director Timothy Leyden Receives Stock Grant

Director Timothy M. Leyden acquired 232 shares of Itron, Inc. common stock as part of his quarterly board compensation.

Summary

• Director Timothy M. Leyden received a grant of 232 shares of Itron, Inc. (ITRI) common stock on April 1, 2026.
• The shares were issued as part of the standard quarterly compensation for independent members of the board of directors.
• Following this transaction, Mr. Leyden holds a total of 16,005 shares of common stock.
• Mr. Leyden elected to defer the receipt of 87 of these shares into the company's Executive Deferred Compensation Plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents standard, recurring director compensation rather than a strategic shift or market-moving event.

Positives

• The transaction reflects standard equity-based compensation for board members, aligning director interests with long-term shareholder value.

Negatives

• None.

Risks

• None.

Future Outlook

Not applicable as this is a routine disclosure of director compensation.

Industry Context

StockSavvy.ai notes that this filing is a routine administrative disclosure regarding director compensation and does not signal a change in corporate strategy or financial performance.

Comparison to Industry Standards

• The issuance of equity as part of board compensation is a standard practice among publicly traded technology and industrial companies to ensure director alignment with shareholders.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine compensation event.

Next Steps

• None.

Key Dates

Keywords

Itron, ITRI, Form 4, Insider Trading, Director Compensation, Equity Grant